A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting LLP found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions. Read More
A new report published by HDA and Deloitte Consulting LLP provides insights into the importance of distributors in driving efficiency and innovation across the pharmaceutical supply chain — both today and over the next several years. It estimates distributors provide between $33–$53 billion in cost savings annually to the healthcare ecosystem. Read More
AmerisourceBergen was able to successfully respond to the unprecedented challenges of the past year because of years of investment in distribution and inventory management, according to executives at the company. As the company has built efficiencies and scale, it has also built confidence in a flexible, reliable network, said Jan Burkett, senior vice president of global specialty branded and consumer products at AmerisourceBergen. Read More
As an industry leader in vaccine distribution, McKesson is prepared to support the U.S. government through Operation Warp Speed to deliver Americans safe and effective COVID-19 vaccines as fast as possible. Earlier this year, the Centers for Disease Control and Prevention (CDC) designated our company as its centralized distribution partner for the U.S. COVID-19 Vaccination Program. And […] Read More
